Cargando…

Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C

Vitamin D receptor (VDR) modulates host immune responses to infections such as hepatitis C virus (HCV) infection, including interferon signaling. This study aimed to investigate the associations of VDR polymorphisms with advanced liver fibrosis and response to pegylated interferon (PEG-IFN)-based th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thanapirom, Kessarin, Suksawatamnuay, Sirinporn, Sukeepaisarnjaroen, Wattana, Tangkijvanich, Pisit, Thaimai, Panarat, Wasitthankasem, Rujipat, Poovorawan, Yong, Komolmit, Piyawat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744935/ https://www.ncbi.nlm.nih.gov/pubmed/31565578 http://dx.doi.org/10.7717/peerj.7666

Ejemplares similares

Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients
por: Thanapirom, Kessarin, et al.
Publicado: (2017)

Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection
por: Thanapirom, Kessarin, et al.
Publicado: (2015)

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial
por: Komolmit, Piyawat, et al.
Publicado: (2017)

Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study
por: Komolmit, Piyawat, et al.
Publicado: (2017)

Stability of hepatitis B virus pregenomic RNA in plasma specimens under various temperatures and storage conditions
por: Rattanachaisit, Pakkapon, et al.
Publicado: (2021)

Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Psychometric Hepatic Encephalopathy Score for the Diagnosis of Minimal Hepatic Encephalopathy in Thai Cirrhotic Patients
por: Thanapirom, Kessarin, et al.
Publicado: (2023)

Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2020)

The association between vitamin D receptor polymorphism and phases of chronic hepatitis B infection in HBV carriers in Thailand
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Association between Vitamin D Receptor Single-Nucleotide Polymorphisms and Colorectal Cancer in the Thai Population: A Case-Control Study
por: Suksawatamnuay, Sirinporn, et al.
Publicado: (2020)

Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2021)

Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study
por: Thanapirom, Kessarin, et al.
Publicado: (2017)

Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study
por: Komolmit, Piyawat, et al.
Publicado: (2020)

Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030
por: Sintusek, Palittiya, et al.
Publicado: (2022)

Prevalence of Thymine—Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection
por: Thong, Vo Duy, et al.
Publicado: (2015)

Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography
por: Teeratorn, Nicha, et al.
Publicado: (2019)

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Circulating Cytokines and Histological Liver Damage in Chronic Hepatitis B Infection
por: Poovorawan, Kittiyod, et al.
Publicado: (2013)

Autoimmune Hepatitis Triggered by COVID-19 Vaccine: The First Case From Inactivated Vaccine
por: Mekritthikrai, Krittaya, et al.
Publicado: (2022)

Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era
por: Poovorawan, Kittiyod, et al.
Publicado: (2016)

Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
por: Wasitthankasem, Rujipat, et al.
Publicado: (2017)

Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai Population
por: Ashouri, Saeideh, et al.
Publicado: (2022)

Hepatopleural Fistula with Empyema Thoracis: A Rare Complication of Autosomal Dominant Polycystic Kidney Disease
por: Maytapa, Jeerawat, et al.
Publicado: (2018)

Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2020)

Acute liver failure and death predictors in patients with dengue-induced severe hepatitis
por: Teerasarntipan, Tongluk, et al.
Publicado: (2020)

Hepatic Necrosis Mimicking Infiltrative Masses in Acute Budd-Chiari Syndrome With Hereditary Protein C Deficiency
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Genotypic Distribution of Hepatitis C Virus in Thailand and Southeast Asia
por: Wasitthankasem, Rujipat, et al.
Publicado: (2015)

Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions
por: Treeprasertsuk, Sombat, et al.
Publicado: (2015)

Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients
por: Sripongpun, Pimsiri, et al.
Publicado: (2019)

Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study
por: Wasitthankasem, Rujipat, et al.
Publicado: (2018)

Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy
por: Wasitthankasem, Rujipat, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b2t2c9hh69vqq0mrdk9e2uh97f